Yu J. Shin
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.
Journal: Cancer biology & therapy
Published: August 25, 2023
Development of finely tuned liposome nanoplatform for macrophage depletion.
Journal: Journal of nanobiotechnology
Published: April 13, 2023
Uric acid regulates α-synuclein transmission in Parkinsonian models.
Journal: Frontiers in aging neuroscience
Published: December 06, 2022
Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria.
Journal: Frontiers in aging neuroscience
Published: January 10, 2022
Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models.
Journal: Stem cell research & therapy
Published: December 26, 2021
Memantine exerts neuroprotective effects by modulating α-synuclein transmission in a parkinsonian model.
Journal: Experimental neurology
Published: December 06, 2020
Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
Journal: Toxicology letters
Published: March 14, 2016
L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.
Journal: Free radical biology & medicine
Published: September 19, 2015
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 04, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026